Delivery Order SPE2DB24D2018-SPE2DB24FWSF1
- Not listed
- This is a $33,153.92 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the supply of BREYNA 160-4.5 MCG INHALER 10.3GM, a medical product. The contract has an ultimate completion date of March 14, 2025 and is not designated as a set-aside. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp's Corporate Office Division. The contract, valued at $2,362.47, is for the supply of a specific pharmaceutical product, the BREYNA 160-4.5 MCG INHALER 10.3GM. The contract has a period of performance through September 3, 2024 and is a firm fixed-price contract. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal contracts to...
- This is a federal delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $4,980.39 firm fixed-price contract is for the delivery of BREYNA 160-4.5 MCG INHALER 10.3GM, a medical supply product. The contract has an ultimate completion date of May 9, 2024. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support...
- This is a $9,016.84 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BREYNA 160-4.5 MCG INHALER 10.3GM, a pharmaceutical product, with a performance period ending on June 18, 2025. The contract is not designated as a set-aside. Amerisourcebergen holds a substantial $999,999,999.00 Indefinite Delivery Contract (IDC) with...
- This is a $10,570.35 firm fixed-price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of BREYNA 160-4.5 MCG INHALER 10.3GM, a medical supply item. This award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, which provides a comprehensive range of...
- This is a delivery order awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a subsidiary of the pharmaceutical distribution company Amerisourcebergen Corporation. The $1,951.88 firm fixed-price contract is for the supply of BREYNA 160-4.5 MCG INHALER 10.3GM, a prescription pharmaceutical product, with a completion date of April 22, 2024. Amerisourcebergen holds an Indefinite Delivery Contract (IDC) valued up to $999,999,999.00 with the DLA Troop Support Medical,...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corporation for the supply of a pharmaceutical product, specifically the BREYNA 160-4.5 MCG INHALER 10.3GM. The contract has a firm fixed price of $2,925.48 and a completion date of September 25, 2024. The contract is not set aside for a specific business category. As one of the largest pharmaceutical distributors in the U.S., AmerisourceBergen leverages its extensive supply chain to provide...
- This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $2,960.82 firm-fixed-price delivery order is for the supply of BREYNA 160-4.5 MCG INHALER 10.3GM medical products. The contract has an ultimate completion date of January 23, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a...
- This is a firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $2,402.18, is for the supply of a specific pharmaceutical product, the BREYNA 160-4.5 MCG INHALER 10.3GM. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp holds a larger Indefinite Delivery Contract (IDC) with the DLA...
- This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,703.04 firm fixed-price contract is for the delivery of BREYNA 160-4.5 MCG INHALER 10.3GM, a medical supply item. The contract has an ultimate completion date of October 17, 2024. Amerisourcebergen is a for-profit organization registered in the System for Award Management (SAM.gov) and...
- SPE2DB24D2018Indefinite Delivery Contract
- SPE2DB24D2018-SPE2DB24FWSF1Delivery Order
This is a $3,030.94 firm fixed-price delivery order contract awarded by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The contract is for the supply of BREYNA 160-4.5 MCG INHALER 10.3GM, a pharmaceutical product, with a period of performance through April 16, 2024. Amerisourcebergen is a subsidiary of the parent company Cencora, Inc. and is a major supplier of pharmaceutical products and medical supplies to the U.S. federal government, particularly the Department of Defense (DoD) and Veterans Affairs (VA) healthcare systems. The contract is not designated as a set-aside and was awarded on a full and open competition basis, highlighting Amerisourcebergen's competitive position in the federal pharmaceutical supply market. Amerisourcebergen also holds a larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, valued up to $999,999,999.00 through December 31, 2025, to provide a comprehensive range of pharmaceutical products and medical supplies to DLA facilities supporting the DoD worldwide.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $3.0k | 4/15/24 |